-- Seed file for company_financials table
INSERT INTO company_financials (id, company_id, year, revenue, r_and_d_spending, net_income)
VALUES
  ('00000000-0000-0000-0000-000000000001', '00000000-0000-0000-0000-000000000001', 2023, 92000000000.00, 13500000000.00, 21000000000.00), -- Pfizer 2023
  ('00000000-0000-0000-0000-000000000002', '00000000-0000-0000-0000-000000000001', 2022, 100000000000.00, 12000000000.00, 31000000000.00), -- Pfizer 2022
  ('00000000-0000-0000-0000-000000000003', '00000000-0000-0000-0000-000000000001', 2021, 81300000000.00, 10500000000.00, 22000000000.00), -- Pfizer 2021
  ('00000000-0000-0000-0000-000000000004', '00000000-0000-0000-0000-000000000002', 2023, 60100000000.00, 13800000000.00, 14500000000.00), -- Merck 2023
  ('00000000-0000-0000-0000-000000000005', '00000000-0000-0000-0000-000000000002', 2022, 59300000000.00, 13500000000.00, 14500000000.00), -- Merck 2022
  ('00000000-0000-0000-0000-000000000006', '00000000-0000-0000-0000-000000000003', 2023, 66800000000.00, 14800000000.00, 12000000000.00), -- Roche 2023
  ('00000000-0000-0000-0000-000000000007', '00000000-0000-0000-0000-000000000003', 2022, 63300000000.00, 13600000000.00, 13000000000.00), -- Roche 2022
  ('00000000-0000-0000-0000-000000000008', '00000000-0000-0000-0000-000000000004', 2023, 45400000000.00, 9900000000.00, 7800000000.00), -- Novartis 2023
  ('00000000-0000-0000-0000-000000000009', '00000000-0000-0000-0000-000000000004', 2022, 50500000000.00, 9500000000.00, 6900000000.00), -- Novartis 2022
  ('00000000-0000-0000-0000-000000000010', '00000000-0000-0000-0000-000000000005', 2023, 45800000000.00, 10100000000.00, 5900000000.00), -- AstraZeneca 2023
  ('00000000-0000-0000-0000-000000000011', '00000000-0000-0000-0000-000000000005', 2022, 44400000000.00, 9500000000.00, 3300000000.00); -- AstraZeneca 2022

-- Seed company_milestones table
INSERT INTO company_milestones (id, company_id, date, title, description, milestone_type)
VALUES
  ('00000000-0000-0000-0000-000000000001', '00000000-0000-0000-0000-000000000001', '2020-12-11', 'COVID-19 Vaccine EUA', 'Received Emergency Use Authorization for COVID-19 vaccine Comirnaty', 'regulatory_approval'),
  ('00000000-0000-0000-0000-000000000002', '00000000-0000-0000-0000-000000000001', '2022-03-15', 'Acquisition of ReViral', 'Completed acquisition of ReViral for $525 million', 'acquisition'),
  ('00000000-0000-0000-0000-000000000003', '00000000-0000-0000-0000-000000000001', '2023-10-05', 'Seagen Acquisition', 'Completed acquisition of Seagen for $43 billion', 'acquisition'),
  ('00000000-0000-0000-0000-000000000004', '00000000-0000-0000-0000-000000000002', '2021-06-30', 'Acceleron Acquisition', 'Completed acquisition of Acceleron Pharma for $11.5 billion', 'acquisition'),
  ('00000000-0000-0000-0000-000000000005', '00000000-0000-0000-0000-000000000002', '2023-01-23', 'Keytruda Expansion', 'FDA approval for Keytruda in adjuvant treatment of NSCLC', 'regulatory_approval'),
  ('00000000-0000-0000-0000-000000000006', '00000000-0000-0000-0000-000000000003', '2022-11-17', 'Alzheimer\'s Therapy Setback', 'Phase 3 trial results showed gantenerumab did not meet primary endpoints', 'clinical_trial'),
  ('00000000-0000-0000-0000-000000000007', '00000000-0000-0000-0000-000000000003', '2021-04-16', 'Acquisition of GenMark', 'Completed acquisition of GenMark Diagnostics for $1.8 billion', 'acquisition'),
  ('00000000-0000-0000-0000-000000000008', '00000000-0000-0000-0000-000000000004', '2022-12-05', 'Spin-off of Sandoz', 'Announced plans to spin off generic drug division Sandoz', 'corporate_restructuring'),
  ('00000000-0000-0000-0000-000000000009', '00000000-0000-0000-0000-000000000004', '2023-09-11', 'Pluvicto Manufacturing Expansion', 'Opened new radioligand therapy manufacturing facility in Indianapolis', 'facility_expansion'),
  ('00000000-0000-0000-0000-000000000010', '00000000-0000-0000-0000-000000000005', '2021-07-15', 'Alexion Acquisition', 'Completed acquisition of Alexion Pharmaceuticals for $39 billion', 'acquisition'),
  ('00000000-0000-0000-0000-000000000011', '00000000-0000-0000-0000-000000000005', '2022-04-08', 'Rare Disease Collaboration', 'Announced strategic collaboration with Neurimmune for rare disease therapies', 'partnership');

-- Seed related_companies table
INSERT INTO related_companies (id, company_id, related_company_id, relationship_type)
VALUES
  ('00000000-0000-0000-0000-000000000001', '00000000-0000-0000-0000-000000000001', '00000000-0000-0000-0000-000000000002', 'competitor'),
  ('00000000-0000-0000-0000-000000000002', '00000000-0000-0000-0000-000000000001', '00000000-0000-0000-0000-000000000003', 'competitor'),
  ('00000000-0000-0000-0000-000000000003', '00000000-0000-0000-0000-000000000002', '00000000-0000-0000-0000-000000000001', 'competitor'),
  ('00000000-0000-0000-0000-000000000004', '00000000-0000-0000-0000-000000000002', '00000000-0000-0000-0000-000000000004', 'competitor'),
  ('00000000-0000-0000-0000-000000000005', '00000000-0000-0000-0000-000000000003', '00000000-0000-0000-0000-000000000004', 'partner'),
  ('00000000-0000-0000-0000-000000000006', '00000000-0000-0000-0000-000000000003', '00000000-0000-0000-0000-000000000005', 'competitor'),
  ('00000000-0000-0000-0000-000000000007', '00000000-0000-0000-0000-000000000004', '00000000-0000-0000-0000-000000000003', 'partner'),
  ('00000000-0000-0000-0000-000000000008', '00000000-0000-0000-0000-000000000004', '00000000-0000-0000-0000-000000000005', 'competitor'),
  ('00000000-0000-0000-0000-000000000009', '00000000-0000-0000-0000-000000000005', '00000000-0000-0000-0000-000000000001', 'competitor'),
  ('00000000-0000-0000-0000-000000000010', '00000000-0000-0000-0000-000000000005', '00000000-0000-0000-0000-000000000002', 'competitor'); 